StockTipsArenaBeta

Sai Life Sciences Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹1,393.6-2.30 (-0.16%)
As of 21 Oct 2026

Only one active 1–3 month target

The short-term call is BUY

₹1,65018.4% above today's price

Sai Life Sciences has one active 1–3 month share price target: ₹1,650 from Swati Hotkar, Nirmal Bang Securities (6 Oct 2026). One target is a single view, not a consensus.

1
1 BUY · 0 SELL, all horizons
1
with an active 1–3M target
38%
5 of 13 closed calls hit
14
all horizons, open and closed
Watch SAILIFE for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (14)

BUYTarget₹1,610
JIbyJefferies IndiaTarget hit
1 Year* · 29 Aug 2026 · entry ₹1,485 · via Financial Express Marketexit ₹1,610
BUYTarget₹1,650
SHbySwati Hotkar, Nirmal Bang Securities+18.4% to target
1–3 Months · 3 mo left · 6 Oct 2026 · entry ₹1,530.1 · via NDTV ProfitP&L -8.9%
BUYTarget₹1,800
HGbyHimanshu GuptaStop-loss hit
1–3 Months · 8 Sept 2026 · entry ₹1,649 · via NDTV Profitexit ₹1,550
BUYTarget₹1,295
SRbySahi ResearchStop-loss hit
1–3 Months · 29 Jun 2026 · entry ₹1,244.5 · via Sahi Research Telegramexit ₹1,210
BUYTarget₹1,233
ICbyIDBI CapitalStop-loss hit
1–3 Months · 29 May 2026 · entry ₹1,165 · via IDBI Capital Research Calls Telegramexit ₹1,131
BUYTarget₹1,635
SBbySumeet Bagadia, Choice BrokingTarget hit
1–2 Weeks* · 2 Sept 2026 · entry ₹1,518 · via LiveMint Buy-or-Sell (topic)exit ₹1,635
BUYTarget₹1,525
SCbyShrikant Chouhan, Kotak SecuritiesTarget hit
1–2 Weeks* · 27 Aug 2026 · entry ₹1,464.9 · via NDTV Profit (Live)exit ₹1,525
BUYTarget₹1,557
ICbyIDBI CapitalTarget hit
1–2 Weeks* · 20 Aug 2026 · entry ₹1,468 · via IDBI Capital Research Calls Telegramexit ₹1,557
BUYTarget₹1,750
RDbyRupak De, LKP SecuritiesStop-loss hit
1–2 Weeks* · 25 Sept 2026 · entry ₹1,591.1 · via Zee Business (Live)exit ₹1,515
BUYTarget₹1,560
PGbyPrakash GabaStop-loss hit
1–2 Weeks* · 20 Aug 2026 · entry ₹1,479 · via CNBC Awaaz.exit ₹1,434
BUYTarget₹1,700
KBbyKunal BothraExpired
1–2 Weeks* · 16 Sept 2026 · entry ₹1,539.5 · via ET Now (Live)exit ₹1,558
BUYTarget₹1,900
SCbyShrikant Chouhan, Kotak SecuritiesExpired
1–2 Weeks* · 16 Sept 2026 · entry ₹1,546.7 · via ET Now (Live)exit ₹1,558
BUYTarget₹1,600
AKbyAshish Kyal, Waves Strategy AdvisorsExpired
1–2 Weeks* · 20 Aug 2026 · entry ₹1,478.2 · via ET Now (Live)exit ₹1,592.7
BUYTarget₹1,280
HSbyHDFC SecuritiesTarget hit
Intraday* · 13 Jul 2026 · entry ₹1,264.6 · via Economic Times New Stock Recosexit ₹1,280

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks